Envista Holdings Corp (NVST)

USD 16.99

(3.98%)

Operating Income Summary of Envista Holdings Corp

Envista Holdings Corp's latest annual operating income in 2023 was 31.5 Million USD , down -90.13% from previous year.
Envista Holdings Corp's latest quarterly operating income in 2024 Q3 was 20.9 Million USD , up 231.75% from previous quarter.
Envista Holdings Corp reported an annual operating income of 319.2 Million USD in 2022, up 4.25% from previous year.
Envista Holdings Corp reported an annual operating income of 306.2 Million USD in 2021, up 819.52% from previous year.
Envista Holdings Corp reported a quarterly operating income of 6.3 Million USD for 2024 Q2, down -88.55% from previous quarter.
Envista Holdings Corp reported a quarterly operating income of 20.9 Million USD for 2024 Q3, up 231.75% from previous quarter.

Annual Operating Income Chart of Envista Holdings Corp (2023 - 2016)

Historical Annual Operating Income of Envista Holdings Corp (2023 - 2016)

Year	Operating Income	Operating Income Growth
2023	31.5 Million USD	-90.13%
2022	319.2 Million USD	4.25%
2021	306.2 Million USD	819.52%
2020	33.3 Million USD	-69.97%
2019	110.9 Million USD	-62.84%
2018	298.4 Million USD	-22.81%
2017	386.6 Million USD	-4.02%
2016	402.8 Million USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	55 Million USD	127.12%
2024 Q2	6.3 Million USD	-88.55%
2024 Q3	20.9 Million USD	231.75%
2023 FY	31.5 Million USD	-90.13%
2023 Q3	83.3 Million USD	5.58%
2023 Q2	78.9 Million USD	9.43%
2023 Q1	72.1 Million USD	-18.07%
2023 Q4	-202.8 Million USD	-343.46%
2022 FY	319.2 Million USD	4.25%
2022 Q4	88 Million USD	169.94%
2022 Q3	32.6 Million USD	-59.25%
2022 Q2	80 Million USD	-12.57%
2022 Q1	91.5 Million USD	98.48%
2021 Q2	98.5 Million USD	-9.05%
2021 FY	306.2 Million USD	819.52%
2021 Q3	81.7 Million USD	-17.06%
2021 Q1	108.3 Million USD	11.88%
2021 Q4	46.1 Million USD	-43.57%
2020 Q3	69.4 Million USD	164.32%
2020 Q4	96.8 Million USD	39.48%
2020 FY	33.3 Million USD	-69.97%
2020 Q1	-25 Million USD	-132.05%
2020 Q2	-107.9 Million USD	-331.6%
2019 Q2	75.9 Million USD	69.04%
2019 FY	110.9 Million USD	-62.84%
2019 Q3	78.7 Million USD	3.69%
2019 Q1	44.9 Million USD	-33.58%
2019 Q4	78 Million USD	-0.89%
2018 Q3	81.4 Million USD	-19.25%
2018 Q1	48.6 Million USD	0.0%
2018 Q2	100.8 Million USD	107.41%
2018 Q4	67.6 Million USD	-16.95%
2018 FY	298.4 Million USD	-22.81%
2017 FY	386.6 Million USD	-4.02%
2016 FY	402.8 Million USD	0.0%

Peer Operating Income Comparison of Envista Holdings Corp

Name	Operating Income	Operating Income Difference
Alcon Inc.	1.03 Billion USD	96.968%
AptarGroup, Inc.	404.01 Million USD	92.203%
Baxter International Inc.	390 Million USD	91.923%
Becton, Dickinson and Company	2.42 Billion USD	98.701%
Bausch + Lomb Corporation	130 Million USD	75.769%
Haemonetics Corporation	164.88 Million USD	80.896%
ResMed Inc.	1.31 Billion USD	97.613%
Teleflex Incorporated	506.31 Million USD	93.779%
Warby Parker Inc.	-71.99 Million USD	143.752%
West Pharmaceutical Services, Inc.	676 Million USD	95.34%